Sanofi Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Sanofi Ventures/Activity

Sanofi Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

4 milestones· JUL 2026 – AUG 2026Show all

Milestone

Portfolio company Epicrispr Biotechnologies closed a $90M Series C co-led by Octagon Capital and Janus Henderson; its EPI-321 epigenetic therapy for FSHD showed positive Phase 1/2 results.

Epicrispr Biotechnologies

Epicrispr Biotechnologies Sanofi Ventures

sanofiventures.comAUG 11, 2026

AUG 11, 2026

Milestone

Portfolio company Expedition Therapeutics completed a $115M Series B led by General Atlantic and dosed its first patient in a Phase 2 COPD trial.

Expedition Therapeutics

Expedition Therapeutics Sanofi Ventures

sanofiventures.comAUG 5, 2026

AUG 5, 2026

Milestone

Portfolio company Draig Therapeutics closed a $65M Series B led by Deep Track Capital, advancing its AMPA receptor potentiator for major depressive disorder.

Draig Therapeutics

Draig Therapeutics Sanofi Ventures

sanofiventures.comJUL 20, 2026

JUL 20, 2026

Milestone

Portfolio company AdvanCell Isotopes closed an oversubscribed $315M Series D to advance its Lead-212 PSMA prostate cancer therapy toward Phase 3.

AdvanCell Isotopes

AdvanCell Isotopes Sanofi Ventures

sanofiventures.comJUL 15, 2026

JUL 15, 2026

Exit

Portfolio company Curevo Vaccine agreed to be acquired by Eli Lilly for up to $1.5B to advance its next-generation shingles vaccine.

Curevo Vaccine

Curevo Vaccine Sanofi Ventures

curevovaccine.comMAY 26, 2026

geekwire.com

MAY 26, 2026

3 investments· OCT 2025 – MAY 2026Show all

Investment

Participated in BranchLab's $26M Series A led by McKesson Ventures, for an AI platform for pharma commercialization.

BranchLab

BranchLab Sanofi Ventures

prnewswire.comMAY 13, 2026

MAY 13, 2026

Investment

Co-led Diagonal Therapeutics' oversubscribed $125M Series B alongside Janus Henderson Investors; Partner Paulina Hill joined the board.

Diagonal Therapeutics

Diagonal Therapeutics Sanofi Ventures

diagonaltx.comJAN 8, 2026

biopharmadive.com

JAN 8, 2026

Investment

Made a strategic investment in QuantHealth, an AI-powered clinical trial simulation platform; Partner Cris De Luca joined the board as observer.

QuantHealth

QuantHealth Sanofi Ventures

sanofiventures.comOCT 1, 2025

mobihealthnews.com

OCT 1, 2025

New Fund

Sanofi committed an additional $625M to Sanofi Ventures, bringing total AUM to over $1.4B, to accelerate biotech and digital health investment.

Additional $625M commitment from Sanofi

Sanofi Ventures

sanofi.comSEP 24, 2025

medcitynews.com

SEP 24, 2025

Exit

Portfolio company Aliada Therapeutics was acquired by AbbVie for $1.4B, a blood-brain-barrier-crossing CNS delivery platform.

Aliada Therapeutics

Aliada Therapeutics Sanofi Ventures

prnewswire.comDEC 11, 2024

news.abbvie.com

DEC 11, 2024

Exit

Portfolio company Escient Pharmaceuticals was acquired by Incyte.

Escient Pharmaceuticals

Escient Pharmaceuticals Sanofi Ventures

sanofiventures.comAPR 2024

APR 2024